Aug
TL;DR: Sculptra is a Health Canada-authorized injectable made from poly-L-lactic acid (PLLA) that prompts your skin to rebuild its own collagen. Results develop gradually across a planned series of sessions, not overnight. In a randomized trial, improvement persisted up to 25 months after the last treatment. However, Sculptra can’t be dissolved the way hyaluronic acid fillers can, so it deserves more deliberation, not less. If you want instant, adjustable volume, an HA filler may fit your goal more closely. If you want slow, structural change that reads as “well rested,” Sculptra belongs on your shortlist.
Biostimulator injections reached 932,861 procedures in the United States in 2024, up 1% year over year (ASPS, 2024). That’s US data, but I watch the same shift in my own consult room here in Guelph. Patients rarely ask for dramatic volume anymore. Instead, they ask how to look less tired without looking “done.” I’m Dr. Dusan Sajic, a dermatologist with a PhD, and collagen biology sits exactly where my research training and my clinical work overlap. Sculptra has become one of my most frequent answers to that question. In this guide, I’ll walk through what it actually does, how long it lasted in published trials, the risks I discuss with every patient, and who should skip it.
Key Takeaways
- Sculptra stimulates your own fibroblasts to produce new collagen, so results build gradually across a planned series of sessions (Narins et al., JAAD, 2010).
- In that randomized trial, improvement persisted up to 25 months after the final treatment; the study was manufacturer-funded, which I always disclose (Narins et al., JAAD, 2010).
- Unlike HA fillers, PLLA can’t be dissolved with hyaluronidase, so choosing your injector carefully matters more, not less (J Cosmet Dermatol, 2025).
- Biostimulators hit 932,861 US procedures in 2024, still well behind the 5,331,426 HA filler treatments performed the same year (ASPS, 2024).
Sculptra is a Health Canada-authorized injectable made from poly-L-lactic acid (PLLA), a biodegradable polymer that surgeons have used in dissolvable sutures for decades. It’s classed as a collagen stimulator, or biostimulator, which separates it from traditional fillers. A hyaluronic acid filler adds volume the instant it’s injected; Sculptra doesn’t. Instead, the PLLA microparticles trigger a controlled repair response in which your own fibroblasts, the cells that manufacture collagen, gradually produce new structural protein where the product was placed. Consequently, results build over weeks to months across a planned series of sessions rather than in one visit. In the pivotal randomized trial comparing injectable PLLA with a human-collagen implant, improvement didn’t just show up; it persisted for up to 25 months after the last treatment (Narins et al., JAAD, 2010). In plain terms, fillers add volume to your face, while Sculptra teaches your face to rebuild its own.
That distinction is why biostimulators anchor my post on where injectables are heading in 2026. Meanwhile, if you’re brand new to needles, my injectables guide for Guelph patients walks through every category first.
Up to 25 months after the final treatment, based on the randomized trial that tracked injectable PLLA against human collagen for nasolabial folds (Narins et al., JAAD, 2010). That said, I disclose two caveats every time: the study was funded by the manufacturer, and individual duration varies. In my practice, I frame Sculptra as roughly a two-year investment.
For context, Radiesse, Sculptra’s biostimulator sibling, is made from calcium hydroxylapatite (CaHA); a 2018 histology study documented new collagen formation, with clinical effect typically lasting 12-18 months (PubMed, 2018). HA cheek fillers, meanwhile, were tracked through the full 24-month follow-up of their pivotal trial (FDA, P110033). Why not just crown a winner from those numbers? Because the studies used different designs, different faces, and different follow-up windows; the chart above is directional, not a head-to-head. I dig into the maintenance side of all three in how long fillers really last.
HA fillers still dominate by volume: US injectors performed 5,331,426 HA filler procedures in 2024 versus 932,861 biostimulator treatments (ASPS, 2024). However, popularity isn’t fit. For me, the honest comparison comes down to three things: speed, reversibility, and what each material actually does under your skin over time.
Speed is the first fork. Dermal fillers made with HA give you same-day volume; Sculptra never will, because collagen takes weeks to build. Reversibility is the second. Hyaluronidase is an enzyme that can dissolve unwanted HA filler, often within days (J Cosmet Dermatol, 2025). No such eraser exists for PLLA, and that single fact, in our experience, should shape how conservatively a first Sculptra series is dosed.
The third factor undermines a common myth. “Temporary” HA isn’t always brief: MRI research detected filler more than two years after injection in all 33 scanned mid-face patients (PRS Global Open, 2024). So both paths are long-term commitments; only one has an exit door.
Here’s how I frame the choice in consults:
Small papules or nodules under the skin are the recognized adverse event with PLLA, and I won’t minimize them. A product whose effect persisted up to 25 months in its trial (Narins et al., JAAD, 2010) is also a product you can’t dissolve on demand, since PLLA doesn’t respond to hyaluronidase (J Cosmet Dermatol, 2025).
The encouraging part is how strongly technique drives that risk. Reported papule and nodule rates dropped substantially as reconstitution and injection methods evolved. In my experience, four habits do most of the protective work:
Consequently, ask any clinic how they reconstitute, how deep they inject, and what aftercare they coach. Vague answers are your cue to keep looking. Expect some short-lived swelling, redness, or bruising at the injection points; we cover the rarer risks one-on-one at your consult.
Sculptra is a course of care, not a single appointment. The pivotal trial delivered injections across multiple planned sessions, then measured improvement for up to 25 months after the last one (Narins et al., JAAD, 2010). Consequently, in our Guelph clinic I map the whole series, and the review schedule, before we book the first vial.
Your first visit is a consultation, not a treatment. I assess bone structure, fat compartments, skin quality, and your medical history, then we decide between Sculptra, Radiesse, an HA option, or no injectable at all. If we proceed, treatment is typically planned across multiple sessions spaced weeks apart, mirroring the trial’s design. Each vial is diluted and hydrated well ahead of time, injected deep, then supported by that massage protocol, and we’ve found that patients who treat aftercare as non-negotiable have the smoothest course. Curious how gradual, structural change actually photographs over a series? Our Sculptra before-and-after gallery shows the arc, case by case.
Biostimulator demand grew again in 2024, up 1% to 932,861 US procedures (ASPS, 2024), and my consult questions have grown with it. Here are the five I hear most.
There’s no universal number, and I won’t invent one. The pivotal trial was built around a short series of injection sessions spaced weeks apart, with improvement then tracked for up to 25 months (Narins et al., JAAD, 2010). In my practice, your series depends on age, skin quality, and volume loss, so we set it together at your consultation.
Gradually, over weeks to months. PLLA stimulates fibroblasts to produce new collagen, so change accumulates between and after sessions instead of appearing immediately (Narins et al., JAAD, 2010). In fact, that same trial followed improvement through 25 months. If you need a visible change for an event next week, an HA filler suits that timeline.
No. Hyaluronidase reverses HA fillers, often within days, but it has no effect on PLLA (J Cosmet Dermatol, 2025). That’s why I dose first series conservatively and build slowly. With trial results persisting up to 25 months (Narins et al., JAAD, 2010), you should feel certain before you start.
Both are collagen stimulators, and I use both. A 2018 histology study confirmed new collagen formation after calcium hydroxylapatite (CaHA) injection, with clinical effect typically lasting 12-18 months (PubMed, 2018). Sculptra builds more slowly and persisted up to 25 months in its own trial. Area, timeline, and tissue quality decide the pick; my Radiesse page covers its side.
Yes. Sculptra is a Health Canada-authorized injectable, and PLLA has decades of medical history in dissolvable sutures. Demand context comes from the US, where biostimulators reached 932,861 procedures in 2024 (ASPS, 2024). However, authorization isn’t suitability. Your health history, medications, and goals decide that, which is exactly what a consultation screens for.
Reading is a good start; a mirror-side conversation tells you more. If improvement that persisted up to 25 months in trial follow-up (Narins et al., JAAD, 2010) appeals to you more than instant volume, request a consultation at deRMA Skin Institute in Guelph. We’ll review your health history, examine your facial structure, and tell you plainly whether Sculptra, another injectable, or no injectable at all fits your goals. And if my answer is “not yet,” you’ll hear that too.
Medically reviewed by Dr. Dusan Sajic, MD, PhD — dermatologist, deRMA Skin Institute, Guelph, ON.
1. American Society of Plastic Surgeons. 2024 Plastic Surgery Statistics Report (US procedural data). https://www.plasticsurgery.org/documents/news/statistics/2024/plastic-surgery-statistics-report-2024.pdf 2. Narins RS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. Journal of the American Academy of Dermatology, 2010 (manufacturer-funded). https://www.sciencedirect.com/science/article/abs/pii/S0190962209009621 3. Histologic study of new collagen formation after calcium hydroxylapatite injection. PubMed, 2018. https://pubmed.ncbi.nlm.nih.gov/29391818/ 4. Review of hyaluronidase and the reversal of hyaluronic acid fillers. Journal of Cosmetic Dermatology, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11733830/ 5. Hyaluronic Acid Filler Longevity in the Mid-face (MRI study). Plastic and Reconstructive Surgery Global Open, 2024. https://journals.lww.com/prsgo/fulltext/2024/07000/hyaluronic_acid_filler_longevity_in_the_mid_face_.36.aspx 6. US FDA. Summary of Safety and Effectiveness Data, P110033 (hyaluronic acid cheek filler pivotal trial). https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110033b.pdf
Dusan Sajic, MD, PhD
Richard Backstein, MD
Sonja Sajic, CCPA
Toni Alberto, CCPA
With more than 20 years of experience, deRMA Skin Institute strive to offer patients the most advanced treatments available to keep their skin healthy and looking its best. Board Certified Dermatologist, Dusan Sajic, MD, PhD, board-certified Plastic and Reconstructive Surgeon, Richard Backstein, MD, FRCSC, Sonja Sajic, CCPA, and Toni Alberto CCPA are committed to providing state-of-the-art medical, surgical and cosmetic treatments to all patients in Guelph, Cambridge, Kitchener, Hamilton, Milton, and surrounding areas.
Fields marked * are required
If you are an existing patient inquiring about appointments and services, please contact
Guelph Cosmetic Department: (888) 803-3762 cosmetic@dermaskininstitute.com
Guelph Medical Department: (519) 836-8558 patientcare@dermaskininstitute.com